Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today announced the pricing of an underwritten public offering of 11,000,000 shares of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Sangamo Therapeutics Announces Pricing of Public Offering of Common StockApril 4, 2019 8:00 AM After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more...)April 3, 2019 5:23 PM Sangamo (SGMO) Offering $115M of Shares at $11.50 Each - BloombergApril 3, 2019 4:13 PM Sangamo Therapeutics (SGMO) Commences Public Offering of Common StockApril 3, 2019 4:01 PM Sangamo/Pfizer Data Competitive, But BioMarin (BMRN) is 'Meaningfully Ahead in Development' - BairdApril 2, 2019 12:45 PM Pre-Open Stock Movers 04/02: (ADMA) (SGMO) (RIOT) Higher; (APYX) (EFOI) (WBA) Lower (more...)April 2, 2019 9:24 AM Sangamo Therapeutics (SGMO) Continues to Gain, Now Up 50%April 2, 2019 8:39 AM Sangamo Therapeutics (SGMO) Hits Pre-Market High, Up 26%April 2, 2019 8:09 AM Sangamo Therapeutics (SGMO) Reports Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy DataApril 2, 2019 7:06 AM Sangamo Therapeutics (SGMO), Pfizer (PFE) Report Phase 1/2 Interim Data For Investigational Hemophilia A Gene TherapyApril 2, 2019 7:01 AM